Oxytocin Richter Drug Interactions

Interaction resulting in a concomitant use is not recommended: Prostaglandins and their analogues: Prostaglandins and their analogues facilitate contraction of the myometrium, hence oxytocin can potentiate the uterine action of prostaglandins and analogues and vice versa (see Contraindications).
Drugs prolonging the QT interval: Oxytocin should be considered as potentially arrhythmogenic, particularly in patients with other risk factors for Torsades de Pointes such as drugs which prolong the QT interval or in patients with history of long QT syndrome (see Precautions).
Interactions to be considered: Caudal anaesthetics: When given during or after caudal block anaesthesia, oxytocin may potentiate the pressor effect of sympathomimetic vasoconstrictor agents.
Vasoconstrictors/Sympathomimetics: Oxytocin may enhance the vasopressor effects of vasoconstrictors and sympathomimetics, even those contained in local anaesthetics.
Inhalation anaesthetics: Inhalation anaesthetics (e.g. cyclopropane, halothane, sevoflurane, desflurane, enflurane) have a relaxing effect on the uterus and produce a notable inhibition of uterine tone and thereby, may diminish the uterotonic effect of oxytocin. Their concurrent use with oxytocin has also been reported to cause cardiac rhythm disturbances.